Merck & Co., Inc. (NYSE:MRK) experienced unusually high options trading on Friday, with investors purchasing 672,962 call options, marking a 1,339% increase in daily call volume. The company holds a “Moderate Buy” consensus rating from analysts with a target price of $126.81, following recent analyst price target increases. Merck also beat its Q4 earnings estimates with $2.04 EPS and $16.4 billion in revenue and announced a quarterly dividend of $0.85 per share.
Merck & Co., Inc. Target of Unusually High Options Trading (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) experienced unusually high options trading on Friday, with investors purchasing 672,962 call options, marking a 1,339% increase in daily call volume. The company holds a “Moderate Buy” consensus rating from analysts with a target price of $126.81, following recent analyst price target increases. Merck also beat its Q4 earnings estimates with $2.04 EPS and $16.4 billion in revenue and announced a quarterly dividend of $0.85 per share.